Product logins

Find logins to all Clarivate products below.


chevron_left

US obesity intervention market

Medtech Resource Center
US Obesity Intervention Market

The rise of GLP-1 receptor agonists is significantly transforming the landscape of obesity treatment, impacting the growth of bariatric procedures and affecting device sales. Innovations and future reimbursements in the GLP-1 space are expected to continue placing downward pressure on the demand for bariatric procedures. Despite this, the growing obese population and increased treatment rates are anticipated to drive the obesity intervention market. Additionally, less-invasive endoluminal procedures and the adoption of innovative technologies that command higher prices will contribute to sustaining the obesity intervention market.

Read our Market Snapshot to access data and analysis on the state of the obesity intervention market in the US from 2019 through 2034.

Related insights

The latest news, technologies, and resources from our team.

United States Transcatheter Heart Valve Device Market United States Transcatheter Heart Valve Device Market
United States Transcatheter Heart Valve Device Market
Latin America Orthopedic Market Latin America Orthopedic Market
Latin America Orthopedic Market
Latin American Interventional Cardiology Device Market Snapshot Latin American Interventional Cardiology Device Market Snapshot
Latin American Interventional Cardiology Device Market Snapshot
chevron_left
chevron_right